| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/12/2007 | WO2006096774A3 Composition and methods for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers |
| 04/12/2007 | WO2006093860A3 Method and composition for repairing heart tissue |
| 04/12/2007 | WO2006081522A3 Modulation of nmda receptor currents via orexin receptor and/or crf receptor |
| 04/12/2007 | WO2006059357A3 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 04/12/2007 | WO2006045796A3 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 04/12/2007 | WO2006045314A3 Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease |
| 04/12/2007 | WO2005060683A3 Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders |
| 04/12/2007 | WO2002086079A3 T1r3 a novel taste receptor |
| 04/12/2007 | US20070082861 Ena nucleic acid drugs modifying splicing in mrna precursor |
| 04/12/2007 | US20070082860 Hla-a24-restricted cancer antigen peptides |
| 04/12/2007 | US20070082849 Angiogenic peptides and uses thereof |
| 04/12/2007 | US20070082848 VEGF-C or VEGF-D materials and methods for treatment of neuropathologies |
| 04/12/2007 | US20070082847 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082845 Ferritin as a therapeutic target in abnormal cells |
| 04/12/2007 | US20070082844 Regulation of food preference using GLP-1 agonists |
| 04/12/2007 | US20070082843 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 04/12/2007 | US20070082842 Therapeutic applications for c-peptide |
| 04/12/2007 | US20070082841 Ocular administration of immunosuppressive agents |
| 04/12/2007 | US20070082840 Combination therapy for inhibition of platelet aggregation |
| 04/12/2007 | US20070082839 Peptide increasing fusiogenic capacity of a gamete |
| 04/12/2007 | US20070082838 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 04/12/2007 | US20070082379 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/12/2007 | US20070082362 Modified soluble t cell receptor |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/12/2007 | US20070082334 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/12/2007 | US20070082076 Glutathione and coffee suppository |
| 04/12/2007 | US20070082065 Therapeutic composition for the treatment of dry eye syndrome |
| 04/12/2007 | US20070082060 Graft materials containing bioactive substances, and methods for their manufacture |
| 04/12/2007 | US20070082043 Liposomal vaccine |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070082040 Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides |
| 04/12/2007 | US20070082002 Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof |
| 04/12/2007 | US20070082001 Novel engineered superantigen for human therapy |
| 04/12/2007 | US20070081994 Chimeric Heteromultimer Adhesins |
| 04/12/2007 | US20070081992 Fusion proteins for blood-brain barrier delivery |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081988 Enzyme inhibitors of PAI-1 |
| 04/12/2007 | US20070081987 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer) |
| 04/12/2007 | US20070081986 Beta-glucuronidase with an attached short peptide of acidic amino acids |
| 04/12/2007 | US20070081985 Lysozyme fortified milk and milk products |
| 04/12/2007 | US20070081984 Compositions and methods for treating hypophosphatasia |
| 04/12/2007 | US20070081976 Bioconjugates comprising sulfated polysaccharides and their uses |
| 04/12/2007 | US20070081975 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | US20070081972 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | US20070081971 Non-glycosylated G-CSF capable of beneficially stabilizing G-CSF without the addition of surfactants and additives derived from human and/or animal origin; long shelf life, physiologically well-tolerated, simple to use and it is possible to dose it precisely |
| 04/12/2007 | US20070081970 G-csf-containing substance for fibroblast recruitment and g-csf-contianing therapeutic agent for wound healing |
| 04/12/2007 | US20070081963 Composition for improving skin conditions comprising human growth hormone as an active ingredient |
| 04/12/2007 | US20070081962 Novel delivery of immune response modifiers for removal of chronic tattoos |
| 04/12/2007 | US20070081961 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
| 04/12/2007 | US20070081960 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity |
| 04/12/2007 | US20070081952 Composition for the treatment of bad breath |
| 04/12/2007 | US20070081943 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | US20070080323 Compositions of lipids and cationic peptieds |
| 04/12/2007 | DE112005000737T5 Mit Heparansulfat-Zuckerketten modifizierte Heparin-bindende Proteine, Verfahren zur Erzeugung derselben und Arzneimittel, welche dieselben enthalten With heparan sulfate sugar chains modified heparin-binding proteins, methods for producing the same and pharmaceutical compositions containing the same |
| 04/12/2007 | CA2627264A1 Factor h for the treatment of chronic nephropathies and production thereof |
| 04/12/2007 | CA2625183A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | CA2624796A1 Combination therapy using budesonide and antisense oligonucleotide targeted to il-4 receptor alpha |
| 04/12/2007 | CA2624587A1 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2 |
| 04/12/2007 | CA2624155A1 Method of producing a modified (poly)peptide |
| 04/12/2007 | CA2624153A1 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 04/12/2007 | CA2624131A1 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 04/12/2007 | CA2623865A1 Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection |
| 04/12/2007 | CA2623864A1 Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
| 04/12/2007 | CA2623094A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2623088A1 Y4 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2622772A1 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | CA2622609A1 The use of an erythropoietin moiety to treat neurodegenerative disorders |
| 04/12/2007 | CA2622042A1 Tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi) -anchors for treatment of cancer and skin lesions |
| 04/12/2007 | CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 04/12/2007 | CA2589422A1 Compositions and methods for inhibiting h. pylori adhesion and infection |
| 04/12/2007 | CA2575827A1 Antiepileptogenic complex of albumin with docosahexaenoate |
| 04/11/2007 | EP1772518A2 Mammalian-type glycosylation in plants |
| 04/11/2007 | EP1772516A1 Pharmaceutical compositions for the treatment of thrombosis |
| 04/11/2007 | EP1772515A1 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772155A1 Medicament for treating avian influenza |
| 04/11/2007 | EP1772154A2 Injectable calcium phosphate pastes for delivery of osteogenic proteins |
| 04/11/2007 | EP1772152A2 Composition for inducing immunotolerance |
| 04/11/2007 | EP1772145A1 Method of effectively using medicine and method concerning prevention of side effect |
| 04/11/2007 | EP1772066A1 Health food, process for producing the same and dried matter or extract |
| 04/11/2007 | EP1771573A2 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 04/11/2007 | EP1771557A2 Gdf3 propeptides and related methods |
| 04/11/2007 | EP1771470A2 Actrii receptor polypeptides, methods and compositions |
| 04/11/2007 | EP1771469A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 04/11/2007 | EP1771464A2 Improved aprotinin variants |
| 04/11/2007 | EP1771207A2 Methods for treating cancer using agents that inhibit wnt16 signaling |
| 04/11/2007 | EP1771202A2 Methods of modulating intracellular degradation rates of toxins |
| 04/11/2007 | EP1771201A2 Compositions and methods for treating or preventing oxalate-related disease |
| 04/11/2007 | EP1771200A1 Physiologically-active composition based on collagen |
| 04/11/2007 | EP1771199A1 Long-acting colloidal insulin formulation and preparation thereof |
| 04/11/2007 | EP1771198A2 Interferon-alpha polypeptides and conjugates |
| 04/11/2007 | EP1771196A1 Ccr ligands for stem cell homing |
| 04/11/2007 | EP1771195A1 Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
| 04/11/2007 | EP1771194A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |